Skip to search.
 TSX Down 0.04% TSX Ventures Down 0.04%

Abbott Laboratories (ABT)

-NYSE
46.33 Down 0.75(1.59%) 4:00PM EDT
|After Hours : 46.31 Down 0.02 (0.04%) 7:25PM EDT
Add to Portfolio
Prev Close:47.08
Open:46.83
Bid:45.79 x 400
Ask:57.25 x 100
1y Target Est:48.61
Beta:1.09
Earnings Date:Apr 14 - Apr 20 (Est.)
Day's Range:46.33 - 46.98
52wk Range:36.65 - 47.88
Volume:5,358,147
Avg Vol (3m):5,611,590
Market Cap:69.91B
P/E (ttm):31.11
EPS (ttm):1.49
Div & Yield:0.96 (2.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 1.59%69.91B
NSRGYDown 1.99%N/A
RHHBYUp 0.50%N/A
TEVADown 0.35%53.07B

Key Statistics

Forward P/E (1 yr):19.22
P/S (ttm):3.51
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :2.15
Quarterly EPS Est (Mar-15) :0.42
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback